Permethrin: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Protected "Permethrin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
No edit summary
Line 1: Line 1:
{{Chembox new
{{DrugProjectFormSinglePage
|   Name = Permethrin
|genericName=generic name
|   ImageFile = Permethrin-2D-skeletal.png
|aOrAn=a
|   ImageSize = 250px
|drugClass=Adrenergic receptor agonist
|   ImageName = Chemical structure of permethrin
|indication=a list of indications, separated by commas.
|   IUPACName = 3-Phenoxybenzyl<br />
|hasBlackBoxWarning=Yes
(1RS)-cis,trans-3-(2,2-dichlorovinyl)<br />-2,2-dimethylcyclopropanecarboxylate<br />
|adverseReactions=a list of adverse reactions, separated by commas.
| Section1 = {{Chembox Identifiers
|blackBoxWarningTitle=Warning Title
|   SMILES = c3ccccc3Oc(c2)cccc2COC(=O)<br />C1C(C1(C)C)C=C(Cl)Cl
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)
  }}
|fdaLIADAdult======Condition 1=====
| Section2 = {{Chembox Properties
 
|   Formula = C<sub>21</sub>H<sub>20</sub>Cl<sub>2</sub>O<sub>3</sub>
* Dosing Information
|  MolarMass = 391.28 g/mol
 
|  Density = 1.19 g/cm³, solid
:* (Dosage)
|   Solubility = Insoluble (5.5 x 10<sup>-3</sup> [[Parts per million|ppm]])
 
|   Appearance = colourless crystals
=====Condition 2=====
|   MeltingPt = 34 °C (307 K)
 
|   BoilingPt = 200 °C (473 K)
* Dosing Information
  }}
 
| Section7 = {{Chembox Hazards
:* (Dosage)
|   ExternalMSDS = [http://physchem.ox.ac.uk/MSDS/PE/permethrin.html External MSDS]
|offLabelAdultGuideSupport======Condition 1=====
|   MainHazards = Irritating to skin and eyes,<br /> damaging to lungs
 
  }}
* Developed by: (Organisation)
| Section8 = {{Chembox Related
 
|   Function = [[pyrethroid]]s
* Class of Recommendation: (Class) (Link)
|   OtherFunctn = [[Bifenthrin]]<br />[[Deltamethrin]]
 
|   OtherCpds =  
* Strength of Evidence: (Category A/B/C) (Link)
  }}
 
}}
* Dosing Information/Recommendation
'''Permethrin''' is a common [[chemical synthesis|synthetic]] chemical, widely used as an [[insecticide]] and [[acaricide]] and as an [[insect repellent]]. It belongs to the family of synthetic chemicals called [[pyrethroid]]s and functions as a [[neurotoxin]], affecting [[neuron]] [[cell membrane|membrane]]s by prolonging sodium channel activation.
 
:* (Dosage)
 
=====Condition 2=====
 
* Developed by: (Organisation)
 
* Class of Recommendation: (Class) (Link)
 
* Strength of Evidence: (Category A/B/C) (Link)
 
* Dosing Information/Recommendation
 
:* (Dosage)
|offLabelAdultNoGuideSupport======Condition 1=====
 
* Dosing Information
 
:* (Dosage)
 
=====Condition 2=====
 
* Dosing Information
 
:* (Dosage)
 
=====Condition 3=====
 
* Dosing Information
 
:* (Dosage)
|fdaLIADPed======Condition 1=====
 
* Dosing Information
 
:* (Dosage)
 
=====Condition 2=====
 
* Dosing Information
 
:* (Dosage)
|offLabelPedGuideSupport======Condition 1=====
 
* Developed by: (Organisation)
 
* Class of Recommendation: (Class) (Link)
 
* Strength of Evidence: (Category A/B/C) (Link)
 
* Dosing Information/Recommendation
 
:* (Dosage)
 
=====Condition 2=====
 
* Developed by: (Organisation)
 
* Class of Recommendation: (Class) (Link)
 
* Strength of Evidence: (Category A/B/C) (Link)
 
* Dosing Information/Recommendation
 
:* (Dosage)
|offLabelPedNoGuideSupport======Condition 1=====
 
* Dosing Information
 
:* (Dosage)
 
=====Condition 2=====
 
* Dosing Information
 
:* (Dosage)
 
=====Condition 3=====
 
* Dosing Information
 
:* (Dosage)
|contraindications=* Condition 1
* Condition 2
* Condition 3
* Condition 4
* Condition 5
|warnings======Conidition 1=====
 
(Description)
 
|clinicalTrials=======Central Nervous System======
 
: (list/description of adverse reactions)
 
======Cardiovascular======
 
: (list/description of adverse reactions)
 
======Respiratory======
 
: (list/description of adverse reactions)
 
======Gastrointestinal======
 
: (list/description of adverse reactions)
 
======Hypersensitive Reactions======
 
: (list/description of adverse reactions)
 
======Miscellaneous======
 
: (list/description of adverse reactions)
 
=====Condition 2=====
 
======Central Nervous System======
 
: (list/description of adverse reactions)
 
======Cardiovascular======
 
: (list/description of adverse reactions)
 
======Respiratory======
 
: (list/description of adverse reactions)
 
======Gastrointestinal======
 
: (list/description of adverse reactions)
 
======Hypersensitive Reactions======
 
: (list/description of adverse reactions)
 
======Miscellaneous======
 
: (list/description of adverse reactions)
|postmarketing=(Description)
|drugInteractions=* Drug 1
* Drug 2
* Drug 3
* Drug 4
* Drug 5
 
=====Drug 1=====
 
(Description)
 
=====Drug 2=====
 
(Description)
 
=====Drug 3=====
 
(Description)
 
=====Drug 4=====
 
(Description)
 
=====Drug 5=====
 
(Description)
|useInPregnancyFDA=(Description)
|useInPregnancyAUS=(Description)
|useInLaborDelivery=(Description)
|useInNursing=(Description)
|useInPed=(Description)
|useInGeri=(Description)
|useInGender=(Description)
|useInRace=(Description)
|useInRenalImpair=(Description)
|useInHepaticImpair=(Description)
|useInReproPotential=(Description)
|useInImmunocomp=(Description)
|othersTitle=Others
|useInOthers=(Description)
 
|administration=(Oral/Intravenous/etc)
|monitoring======Condition 1=====
 
(Description regarding monitoring, from ''Warnings'' section)
 
=====Condition 2=====
 
(Description regarding monitoring, from ''Warnings'' section)
 
=====Condition 3=====
 
(Description regarding monitoring, from ''Warnings'' section)
|IVCompat====Solution===
 
====Compatible====
 
* Solution 1
* Solution 2
* Solution 3
 
====Not Tested====
 
* Solution 1
* Solution 2
* Solution 3
 
====Variable====
 
* Solution 1
* Solution 2
* Solution 3
 
====Incompatible====
 
* Solution 1
* Solution 2
* Solution 3
 
===Y-Site===
 
====Compatible====
 
* Solution 1
* Solution 2
* Solution 3
 
====Not Tested====
 
* Solution 1
* Solution 2
* Solution 3
 
====Variable====
 
* Solution 1
* Solution 2
* Solution 3
 
====Incompatible====
 
* Solution 1
* Solution 2
* Solution 3
 
===Admixture===
 
====Compatible====
 
* Solution 1
* Solution 2
* Solution 3
 
====Not Tested====
 
* Solution 1
* Solution 2
* Solution 3
 
====Variable====
 
* Solution 1
* Solution 2
* Solution 3
 
====Incompatible====
 
* Solution 1
* Solution 2
* Solution 3
 
===Syringe===
 
====Compatible====
 
* Solution 1
* Solution 2
* Solution 3
 
====Not Tested====
 
* Solution 1
* Solution 2
* Solution 3
 
====Variable====
 
* Solution 1
* Solution 2
* Solution 3
 
====Incompatible====
 
* Solution 1
* Solution 2
* Solution 3


==Uses==
===TPN/TNA===


In agriculture, Permethrin is mainly used on [[cotton]], [[wheat]], [[maize]], and [[alfalfa]] crops, and is also used to kill [[parasite]]s on [[chicken]]s and other [[poultry]]. Its use is controversial since, as a [[broad-spectrum]] chemical, it kills indiscriminately; as well as the intended pests, it can harm beneficial insects including [[honey bee]]s, aquatic life,<ref>{{cite journal | author = R. H. Ian | title = Aquatic organisms and pyrethroids | year = 1989 | journal = [[Pesticide Science]] | volume = 27 | issue = 4 | pages = 429-457 | doi = 10.1002/ps.2780270408}}</ref> and small mammals such as [[mouse|mice]].
====Compatible====


However, permethrin can be used in a targeted manner as well. This is the basis for a method of reducing populations of the [[deer tick]] ''Ixodes scapularis'' (''I. dammini''). Biodegradable cardboard tubes stuffed with permethrin-treated cotton, are sold under the brand name ''Damminix'',<ref>{{cite web | title = Damminix Tick Tubes (Official site) | url = http://www.ticktubes.com/}}</ref> Mice collect the cotton for lining their nests, and the pesticide on the cotton kills any immature ticks that are feeding on the mice.<ref name="Property Protection">{{Cite web | title = Lyme disease and related tick-borne infections | url = http://www.umm.edu/patiented/articles/how_can_lyme_disease_other_tick-borne_infections_be_prevented_000016_8.htm  | date = 18 Jan 07 | publisher = University of Maryland Medical Center}}</ref>
* Solution 1
* Solution 2
* Solution 3


Permethrin is also used in healthcare, to eradicate parasites such as [[head lice]] and mites responsible for [[scabies]], and in industrial and domestic settings to control pests such as [[ant]]s and [[termite]]s.
====Not Tested====


Permethrin kills ticks on contact with treated clothing. According to the [[Connecticut Department of Public Health]], it "has low mammalian toxicity, is poorly absorbed through the skin and is rapidly inactivated by the body. Skin reactions have been uncommon."<ref>{{cite web | url = http://www.dph.state.ct.us/BCH/infectiousdise/tickborne/tick.htm#Permethrin | title = Tick Bite Prevention | author = Kirby C. Stafford III | date = Feb 1999 | publisher = Connecticut Department of Public Health}}</ref>
* Solution 1
* Solution 2
* Solution 3


Permethrin is used in tropical areas to prevent [[mosquito]]-borne disease such as [[Dengue fever]] and [[malaria]]. Mosquito nets used to cover beds may be treated with a solution of permethrin. Military personnel training in malaria-endemic areas may be instructed to treat their uniforms with permethrin as well. An application should last several washes.
====Variable====


Recently, in [[South Africa]], residues of permethrin were found in breast milk, together with DDT, in an area that experience [[DDT]] treatment for malaria control, as well as the use of pyrethroids in small-scale agriculture.<ref>{{cite journal | author = H. Bouwman, B. Sereda and H. M. Meinhardt | title = Simultaneous presence of DDT and pyrethroid residues in human breast milk from a malaria endemic area in South Africa | year = 2006 | journal = [[Environmental Pollution]] | volume = 144 | issue = 3 | pages = 902-917 | doi = 10.1016/j.envpol.2006.02.002}}</ref>
* Solution 1
* Solution 2
* Solution 3


==Products containing permethrin==
====Incompatible====
Products containing 0.5% permethrin:


* [[Repel Permanone]]
* Solution 1
*
* Solution 2
* [[Permethrin Tick Repellent]]
* Solution 3
|overdose====Acute Overdose===


* Bonide Ant Dust (0.25%)
====Signs and Symptoms====


* Nix 1% shampoo for [[head lice]].
(Description)


* [[Elimite]] 5% skin cream or generic equilvalent for [[scabies]], [[lice]], [[head lice]], [[bird mites]], [[tropical rat mites]], [[bed bugs]], and other [[mites]].
====Management====


* Most [[flea]] and tick repellant for dogs (Adams, Bio-Spot, K9-Advantix, Cutter)
(Description)


* Dragnet, a pesticide for home use, also contains permethrin.
===Chronic Overdose===


* Raid Ant and Roach killer, another home insecticide contains 2% permethrin.
====Signs and Symptoms====


* [[Cutter]] Bug Free Backyard
(Description)
<BR>
Products containing 12.6% permethrin:


* [[Raid (insecticide)|Raid]] fumigator
====Management====


==Stereochemistry==
(Description)
Permethrin has four [[Stereoisomerism|stereoisomers]] (two [[enantiomer|enantiomeric pairs]]), arising from the two [[stereocenter|stereocentres]] in the [[cyclopropane]] ring.  The ''[[trans]]'' enantiomeric pair is known as '''transpermethrin'''.
|drugBox={{Drugbox2
| verifiedrevid =  
| IUPAC_name =  
| image =  
| drug_name =


<gallery>
<!--Clinical data-->
Image:Biopermethrin-2D-skeletal.png|<center>''(1R)''-''trans''-acid moiety, known as '''biopermethrin'''</center>
| tradename =
Image:(1S)-trans-permethrin.svg|<center>''(1S)''-''trans''-acid moiety</center>
| MedlinePlus =
Image:Cis-permethrin-A-2D-skeletal.png |<center>one ''cis'' [[enantiomer]]</center>
| licence_US =
Image:Cis-permethrin-B-2D-skeletal.png |<center>the other ''cis'' enantiomer</center>
| pregnancy_AU =
</gallery>
| pregnancy_US =
| legal_status =
| routes_of_administration =


==Toxicity==
<!--Pharmacokinetic data-->
Permethrin is extremely toxic to fish. Extreme care must be taken when using products containing permethrin near water sources.
| bioavailability =  
Permethrin is also highly toxic to cats. Flea and tick repellent formulas intended (and labeled) for dogs may contain permethin and cause feline permethrin toxicosis in cats: specific flea and tick control formulas intended for feline use, such as those containing [[fipronil]], should therefore be used for cats instead.
| metabolism =  
| elimination_half-life =  
| excretion =  


Currently, permethrin is not considered a carcinogen by any recognized authoritative body, but a few studies have lead the US EPA to classify the substance as a Category C carcinogen: Possible human carcinogen (the data show limited evidence of carcinogenicity in the absence of human data)<ref>[http://www.pested.psu.edu/infocenter/issues/fqpacanctab.pdf]US EPA List of Chemicals Evaluated for Carcinogenic Potential</ref>. Carcinogenic action in nasal mucosal cells for inhalation exposure is suspected due to observed genotoxicity in human tissue samples, and in rat livers the evidence of increased preneoplastic lesions lends concern over oral exposure.<ref>{{cite journal | author = M. Tisch, P. Schmezer, M. Faulde, A. Groh and H. Maier | title = Genotoxicity studies on permethrin, DEET and diazinon in primary human nasal mucosal cells | year = 2002 | journal = [[European Archives of Oto-Rhino-Laryngology]] | volume = 259 | issue = 3 | pages = 150-153 | doi = 10.1007/s004050100406}}</ref><ref>{{cite journal | author = K. Hakoi, R. Cabral, T. Hoshiya, R. Hasegawa, T. Shirai and N. Ito | title = Analysis of carcinogenic activity of some pesticides in a medium-term liver bioassay in the rat | year = 1992 | journal = [[Teratogenesis, Carcinogenesis, and Mutagenesis]] | volume = 12 | issue = 6 | pages = 269-276 | doi = 10.1002/tcm.1770120605}}</ref> However, these results are seen as preliminary and marginal, at best.
<!--Identifiers-->
| CAS_number_Ref =
| CAS_number =
| ATC_prefix =  
| ATC_suffix =  
| PubChem =  
| IUPHAR_ligand =  
| DrugBank_Ref =  
| DrugBank =  
| ChemSpiderID_Ref =  
| ChemSpiderID =  
| UNII_Ref =  
| UNII =  
| KEGG_Ref =  
| KEGG =  
| ChEBI_Ref =  
| ChEBI =  
| ChEMBL_Ref =  
| ChEMBL =  


==References==
<!--Chemical data-->
<references/>
| C= | H= | N= | O=
| molecular_weight =  
| smiles =  
| InChI =  
| InChIKey =  
| StdInChI_Ref =
| StdInChI =
| StdInChIKey_Ref =
| StdInChIKey =
| melting_point =
}}
|mechAction=(Description)
|structure=(Description with picture)
|PD=(Description)
|PK=(Description)
|nonClinToxic=(Description)
|clinicalStudies======Condition 1=====


==See also==
(Description)
* [[Methoprene]]


==External links==
=====Condition 2=====
* [http://npic.orst.edu/factsheets/permethrin.pdf Permethrin Fact Sheet - National Pesticide Information Center]
* [http://npic.orst.edu/hottopic/PermethrinTreatedClothes.pdf Permethrin-treated Clothing Hot Topic - National Pesticide Information Center]
* [http://extoxnet.orst.edu/pips/permethr.htm Permethrin Pesticide Information Profile - Extension Toxicology Network]
* [http://www.alanwood.net/pesticides/permethrin.html Permethrin chemical data]
* [http://www.therossendalefreepress.co.uk/news/s/212/212931_firm_fined_over_irwell_pollution.html Example of permethrin river poisoning]


{{Ectoparasiticides}}
(Description)


[[Category:Antiparasitic agents]]
=====Condition 3=====
[[Category:Household chemicals]]
[[Category:Organochlorides]]
[[Category:Phenol ethers]]
[[Category:Pyrethroids]]


[[de:Permethrin]]
(Description)
[[fr:Perméthrine]]
|howSupplied=(Description)
[[it:Permetrina]]
|fdaPatientInfo=(Patient Counseling Information)
[[nl:Permethrin]]
|nlmPatientInfo=(Link to patient information page)
[[fi:Permetriini]]
|lookAlike=* (Paired Confused Name 1a) — (Paired Confused Name 1b)
* (Paired Confused Name 2a) — (Paired Confused Name 2b)
* (Paired Confused Name 3a) — (Paired Confused Name 3b)
|drugShortage=Drug Shortage
}}

Revision as of 15:05, 22 December 2014

Permethrin
Black Box Warning
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

Warning Title
See full prescribing information for complete Boxed Warning.
Condition Name: (Content)

Overview

Permethrin is a Adrenergic receptor agonist that is FDA approved for the {{{indicationType}}} of a list of indications, separated by commas.. There is a Black Box Warning for this drug as shown here. Common adverse reactions include a list of adverse reactions, separated by commas..

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Condition 1
  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Condition 1
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)
Condition 2
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)

Non–Guideline-Supported Use

Condition 1
  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)
Condition 3
  • Dosing Information
  • (Dosage)

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Condition 1
  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition 1
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)
Condition 2
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)

Non–Guideline-Supported Use

Condition 1
  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)
Condition 3
  • Dosing Information
  • (Dosage)

Contraindications

  • Condition 1
  • Condition 2
  • Condition 3
  • Condition 4
  • Condition 5

Warnings

Warning Title
See full prescribing information for complete Boxed Warning.
Condition Name: (Content)
Conidition 1

(Description)

Adverse Reactions

Clinical Trials Experience

Central Nervous System
(list/description of adverse reactions)
Cardiovascular
(list/description of adverse reactions)
Respiratory
(list/description of adverse reactions)
Gastrointestinal
(list/description of adverse reactions)
Hypersensitive Reactions
(list/description of adverse reactions)
Miscellaneous
(list/description of adverse reactions)
Condition 2
Central Nervous System
(list/description of adverse reactions)
Cardiovascular
(list/description of adverse reactions)
Respiratory
(list/description of adverse reactions)
Gastrointestinal
(list/description of adverse reactions)
Hypersensitive Reactions
(list/description of adverse reactions)
Miscellaneous
(list/description of adverse reactions)

Postmarketing Experience

(Description)

Drug Interactions

  • Drug 1
  • Drug 2
  • Drug 3
  • Drug 4
  • Drug 5
Drug 1

(Description)

Drug 2

(Description)

Drug 3

(Description)

Drug 4

(Description)

Drug 5

(Description)

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): (Description)
Pregnancy Category (AUS): (Description)

Labor and Delivery

(Description)

Nursing Mothers

(Description)

Pediatric Use

(Description)

Geriatic Use

(Description)

Gender

(Description)

Race

(Description)

Renal Impairment

(Description)

Hepatic Impairment

(Description)

Females of Reproductive Potential and Males

(Description)

Immunocompromised Patients

(Description)

Others

(Description)

Administration and Monitoring

Administration

(Oral/Intravenous/etc)

Monitoring

Condition 1

(Description regarding monitoring, from Warnings section)

Condition 2

(Description regarding monitoring, from Warnings section)

Condition 3

(Description regarding monitoring, from Warnings section)

IV Compatibility

Solution

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Y-Site

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Admixture

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Syringe

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

TPN/TNA

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Overdosage

Acute Overdose

Signs and Symptoms

(Description)

Management

(Description)

Chronic Overdose

Signs and Symptoms

(Description)

Management

(Description)

Pharmacology

Permethrin
Systematic (IUPAC) name
?
Identifiers
CAS number ?
ATC code ?
PubChem ?
Chemical data
Formula ?
Mol. mass ?
Pharmacokinetic data
Bioavailability ?
Metabolism ?
Half life ?
Excretion ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes ?

Mechanism of Action

(Description)

Structure

(Description with picture)

Pharmacodynamics

(Description)

Pharmacokinetics

(Description)

Nonclinical Toxicology

(Description)

Clinical Studies

Condition 1

(Description)

Condition 2

(Description)

Condition 3

(Description)

How Supplied

(Description)

Storage

There is limited information regarding Permethrin Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Permethrin |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Permethrin |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

(Patient Counseling Information)

Precautions with Alcohol

Alcohol-Permethrin interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Permethrin Brand Names in the drug label.

Look-Alike Drug Names

  • (Paired Confused Name 1a) — (Paired Confused Name 1b)
  • (Paired Confused Name 2a) — (Paired Confused Name 2b)
  • (Paired Confused Name 3a) — (Paired Confused Name 3b)

Drug Shortage Status

Drug Shortage

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

Retrieved from "https://www.wikidoc.org/index.php?title=Permethrin&oldid=1049773"